Elisa Liverani

Dr. Elisa Liverani


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 April 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
CBCecilia Binda
Cecilia Binda
MSMatteo Secco
Matteo Secco
LTLuigi Tuccillo
Luigi Tuccillo
CCChiara Coluccio
Chiara Coluccio
ELElisa Liverani
Elisa Liverani
GGGiulia Gibiino
Giulia Gibiino
A rise in the incidence of early rectal cancer consequent to bowel-screening programs around the world and an increase in the incidence in young adults has led to a growing interest in organ-sparing treatment options. The rectum, being the most distal portion of the large intestine, is a fertile ground for local excision techniques performed with endoscopic or surgical techniques. Moreover, the advancement in endoscopic optical evaluation and the better definition of imaging techniques allow for a more precise local staging of early rectal cancer. Although the local treatment of early rectal cancer seems promising, in clinical practice, a significant number of patients who could benefit from local excision techniques undergo total mesorectal excision (TME) as the first approach. All relevant prospective clinical trials were identified through a computer-assisted search of the PubMed, EMBASE, and Medline databases until January 2024. This review is dedicated to endoscopic and surgical local excision in the treatment of early rectal cancer and highlights its possible role in current and future clinical practice, taking into account surgical completion techniques and chemoradiotherapy.

2 November 2023 in Medicina
Verified
Journal Article
Open access
PDF file
GGGiulia Gibiino
Giulia Gibiino
CBCecilia Binda
Cecilia Binda
MSMatteo Secco
Matteo Secco
PGPaolo Giuffrida
Paolo Giuffrida
CCChiara Coluccio
Chiara Coluccio
CFCarlo Fabbri
Carlo Fabbri
Postoperative non variceal upper gastrointestinal haemorrhage may occur early or late and affect a variable percentage of patients—up to about 2%. Most cases of intraluminal bleeding are an indication for urgent Esophagogastroduodenoscopy (EGD) and require endoscopic haemostatic treatment. In addition to the approach usually adopted in non-variceal upper haemorrhages, these cases may be burdened with difficulties in terms of anastomotic tissue, angled positions, and the risk of further complications. There is also extreme variability related to the type of surgery performed, in the context of oncological disease or bariatric surgery. At the same time, the world of haemostatic devices available in digestive endoscopy is increasing, meeting high efficacy rates and attempting to treat even the most complex cases. Our narrative review summarises the current evidence in terms of different approaches to endoscopic haemostasis in upper bleeding in altered anatomy after surgery, proposing an up-to-date guidance for endoscopic clinicians and at the same time, highlighting areas of future scientific research.

18 August 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
CJCarlo Felix Maria Jung
Carlo Felix Maria Jung
CBCecilia Binda
Cecilia Binda
LTLuigi Tuccillo
Luigi Tuccillo
MSMatteo Secco
Matteo Secco
GGGiulia Gibiino
Giulia Gibiino
CFCarlo Fabbri
Carlo Fabbri
Post-sleeve gastrectomy fistulas are a rare but possibly severe life-threatening complication. Besides early reoperation and drainage, endoscopy is the main treatment option. According to the clinical setting, endoscopic treatment options comprise stent or clip placement. New endoscopic therapies have recently gained attention, including endoscopic vacuum therapy, VacStent therapy, endoscopic internal drainage with pigtail stents, endoscopic suturing and stem cell injection. In this narrative review, we shed light on recent literature, developments, indications and contraindications of these treatments. Intragastric gastric band migration is a rare complication after gastric band positioning. Reoperation can sometimes be difficult, especially when a gastric band has already migrated far into the stomach. Endoscopic retrieval can be a valid, non-invasive therapeutic solution. We reviewed the current literature on this matter.

15 August 2024 in Diagnostics
Verified
Journal Article
Open access
PDF file
CJCarlo Felix Maria Jung
Carlo Felix Maria Jung
ELElisa Liverani
Elisa Liverani
CBCecilia Binda
Cecilia Binda
LCLudovica Cristofaro
Ludovica Cristofaro
AGAlberto Gori
Alberto Gori
CFCarlo Fabbri
Carlo Fabbri
Introduction: Percutaneous ultrasound-guided radiofrequency ablation (RFA) is a well-studied treatment option for locally non-advanced hepatocellular carcinoma (HCC) and colorectal liver metastases (CRLMs). Sedation is of crucial interest as it enables safe and pain-free procedures. Whether the type of sedation has an impact on procedural outcome is still not well investigated. Methods: We retrospectively collected data on patients undergoing liver RFA for various oncological conditions. Procedures were conducted in a non-operating room anesthesia (NORA) setting. Procedural-related complications and short-term oncological outcomes were analyzed. Results: Thirty-five patients (mean age 71.5 y, 80% male) were treated for HCC (26), CRLM (6) and gastric cancer metastases (3). Mean lesion size was 21 mm (SD ± 10.1 mm), and the most common tumor localization was the right hepatic lobe. RFA was performed in a step-up sedation approach, with subcutaneous lidocaine injection prior to needle placement and subsequent deep sedation during ablation. No anesthesia-related early or late complications occurred. One patient presented with pleural effusion due to a large ablation zone and was treated conservatively. Local tumor-free survival after 1 and 6 months was 100% in all cases where a curative RFA approach was intended. Conclusions: NORA for liver RFA comes with high patient acceptance and tolerance, and optimal postoperative outcomes and oncologic results.